세계의 원격 환자 모니터링(RPM) 시장 : 구성요소별, 적응증별, 최종사용자별, 지역별 - 예측(-2030년)

The global remote patient monitoring market is projected to reach USD 56.94 billion by 2030 from 27.72 billion in 2024, at a CAGR of 12.7% from 2024 to 2030. Reason for growth in the remote patient monitoring market: More individuals are getting hospital-acquired infections (HAIs) such as bloodstream infections, urinary tract infections, pneumonia, and infections caused by C. difficile. These infections have been associated with critical health complications and death in hospitals, hence the solutions that monitor patients remotely have been necessary in the prevention and management of risks. Further, the incidence of chronic diseases such as cardiovascular diseases, obesity, and diabetes is rising, which in turn increases the demand for effective remote monitoring technologies. The cost of healthcare in the US has substantially deteriorated; almost half of US adults are struggling to afford prescription drugs and doctor visits. This affordability issue challenges patients to use remote patient monitoring technologies since they are experiencing difficulties coming up with money for basic healthcare services, not to mention coming up with money for new digital tools.

"Cloud based deployment is the fastest segment in the remote patient monitoring software by deployment market in 2023"

Cloud-based deployment is expected to be the fastest-growing segment in the remote patient monitoring market during 2023, mainly because this model has several advantages, such as easy integration of data from multiple cloud sources, unlimited access by users from remote locations, low maintenance costs, high security and privacy, easy access, no need to buy hardware up front, and excellent flexibility in the use of capacity and resources. A plethora of applications made accessible through the cloud-based model with core functionalities involving accounting, performance management, and also webmails and instant messages are all proving to be helpful in fueling this particular portion.

"North America dominated the remote patient monitoring market in 2023."

The remote patient monitoring market is segmented into five major regional segments, namely, North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The North American region dominated the remote patient monitoring market because of several factors such as substantially high adoption rates of healthcare technologies, a robust and well-established infrastructure in healthcare, and constant growth in healthcare spending that supports such progress. In addition, the increasing trend in the chronic diseases patients suffer from and the increasing need for home healthcare solutions will also increase growth in this region's market. According to the Department of Health and Human Services' Office of Inspector General report, that Medicare enrolees receiving RPM increased more than 10-fold from 55,000 in 2019 to 570,000 in 2022, indicating a substantial increase in adoption.

The break-down of primary participants is as mentioned below:

• By Company Type - Tier 1: 40%, Tier 2: 35%, and Tier 3: 25%
• By Designation - C-level: 35%, Director-level: 40%, and Others: 25%
• By Region - North America: 45%, Europe: 30%, Asia Pacific: 20%, Latin America: 3%, and Middle East & Africa: 2%.

Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), OMRON Corporation (Japan), GE Healthcare (US), Oracle (US), Boston Scientific Corporation (US), Abbott (US), NIHON KOHDEN CORPORATION (Japan), Siemens Healthineers AG (Germany), Baxter (US), Biobeat (Israel), Biotronik (Germany), and VitalConnect (US) are some of the key players in the remote patient monitoring market.

• The study includes an in-depth competitive analysis of these key players in the remote patient monitoring market, with their company profiles, recent developments, and key market strategies.

Research Coverage

This research report categorizes the remote patient monitoring market by component (devices by function [cardiac monitoring devices, neurological monitoring devices, respiratory monitoring devices, blood glucose monitoring devices, fetal & neonatal monitoring devices, weight monitoring devices, multiparameter monitoring devices, pulse oximeter devices, thermometers, other monitoring devices (rehabilitation and physical therapy devices, fall detection devices, and others)], by product type- [wearable devices, implantable devices, handheld & portable devices, others (stationary devices, and others)], software by deployment- [on-premise model and cloud-based model], by transmission type- [synchronous and asynchronous], and services). By indication (oncology, cardiology, neurology, diabetes, sleep disorders, respiratory diseases, wellness improvement (weight management, fitness monitoring, hydration monitoring, nutritional tracking & monitoring, etc), mental health, and others (obstetrics & gynecology, immunology, infectious diseases, metabolic disorders, ophthalmology, gastroenterology, nephrology & urology, hematology, endocrinology, musculoskeletal disorders, and others)). By end user (healthcare providers [hospitals, ambulatory surgical centers, ambulatory care centers, and other outpatient settings, long term care & assisted living facilities, home healthcare, and other healthcare providers (diagnostics & imagining centers, rehabilitation centers, behavioural health centers, and others)], healthcare payers, patients, pharmaceutical & biotechnology companies, medTech companies, and other end users (employer groups, government organizations, academic institutes, research centers, and others)), and by region (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the remote patient monitoring market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; partnerships, agreements. new product & service launches, regulatory approval, investment, fundings, mergers and acquisitions, and recent developments associated with the remote patient monitoring market. Competitive analysis of upcoming startups in the remote patient monitoring market ecosystem is covered in this report.

Reasons to buy this report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the remote patient monitoring market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

• Analysis of key drivers (transforming patient care through digital innovation, telehealth driving growth in remote patient monitoring, rising prevalence of chronic diseases, growing geriatric population globally, need for cost-containment and improved patient care in healthcare industry, and wearables, health apps and connected devices enhancing remote patient monitoring solutions) restraints (high investments and lack of it expertise, behavioral barriers and healthcare affordability challenges in remote patient monitoring, and regulatory barriers in 2024 medicare policies impacting remote patient monitoring) opportunities (emergence of AI & ML, growing shift toward outpatient care environments, growing use in combating infectious diseases and enhanced patient care through early detection, hospital-at-home, and enhanced patient care through early detection and continuous monitoring) challenges (growing data security concerns data security issues, data accessibility issues, and integration of social determinants of health (sdoh) factors into rpm programs) influencing the growth of the remote patient monitoring market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the remote patient monitoring market
• Market Development: Comprehensive information about lucrative markets - the report analyses the remote patient monitoring market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the remote patient monitoring market
• Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players such as Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), OMRON Corporation (Japan), GE Healthcare (US), Boston Scientific Corporation (US), Abbott (US), NIHON KOHDEN CORPORATION (Japan), and Siemens Healthineers AG); among others in the remote patient monitoring market

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 MARKET SCOPE
  • 1.3.1 MARKET SEGMENTATION
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 LIMITATIONS
• 1.5 STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Breakdown of primary sources
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 SUPPLY-SIDE ANALYSIS
  • 2.2.2 BOTTOM-UP APPROACH: END-USER ADOPTION
  • 2.2.3 TOP-DOWN OF PARENT MARKET ASSESSMENT
  • 2.2.4 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
• 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
• 2.4 RESEARCH ASSUMPTIONS
  • 2.4.1 MARKET SIZING ASSUMPTIONS
  • 2.4.2 OVERALL STUDY ASSUMPTIONS
• 2.5 RISK ASSESSMENT
• 2.6 RESEARCH LIMITATIONS
  • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.6.2 SCOPE-RELATED LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 REMOTE PATIENT MONITORING MARKET OVERVIEW
• 4.2 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY END USER AND REGION (2023)
• 4.3 GEOGRAPHIC GROWTH OPPORTUNITIES
• 4.4 REMOTE PATIENT MONITORING MARKET: DEVELOPED MARKETS VS. EMERGING MARKETS

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
  • 5.1.1 DRIVERS
    • 5.1.1.1 Transformation of patient care through digital innovation
    • 5.1.1.2 Expansion of telehealth in remote patient monitoring
    • 5.1.1.3 Rising prevalence of chronic diseases
    • 5.1.1.4 Increasing geriatric population and rising uptake of RPM services
    • 5.1.1.5 Growing need for cost-containment across healthcare facilities
    • 5.1.1.6 Technological innovation in wearables, mhealth apps, and connected devices
  • 5.1.2 RESTRAINTS
    • 5.1.2.1 High investments and lack of IT expertise
    • 5.1.2.2 Behavioral barriers and healthcare affordability challenges in remote patient monitoring
    • 5.1.2.3 Challenges associated with 2024 CMS regulations
  • 5.1.3 OPPORTUNITIES
    • 5.1.3.1 Emergence of AI & ML
    • 5.1.3.2 Gradual shift toward outpatient care environments
    • 5.1.3.3 Increasing utilization for infectious disease diagnostics
    • 5.1.3.4 Rising initiatives for hospital-at-home programs
  • 5.1.4 CHALLENGES
    • 5.1.4.1 Concerns associated with data security
    • 5.1.4.2 Data accessibility issues
    • 5.1.4.3 incorporation of SDOH factors into RPM programs
• 5.2 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.2.1 REVENUE SHIFTS AND NEW REVENUE POCKETS FOR REMOTE PATIENT MONITORING MARKET
• 5.3 INDUSTRY TRENDS
  • 5.3.1 GRADUAL SHIFT TO VALUE-BASED & PATIENT-CENTRIC CARE
• 5.4 ECOSYSTEM ANALYSIS
• 5.5 VALUE CHAIN ANALYSIS
• 5.6 TECHNOLOGY ANALYSIS
  • 5.6.1 KEY TECHNOLOGIES
    • 5.6.1.1 Miniature wearable devices
    • 5.6.1.2 Artificial intelligence & machine learning
    • 5.6.1.3 Cloud computing
    • 5.6.1.4 Patient engagement tools
    • 5.6.1.5 EHR integration
    • 5.6.1.6 Voice assistant integration
  • 5.6.2 COMPLEMENTARY TECHNOLOGIES
    • 5.6.2.1 5G connectivity
    • 5.6.2.2 mHealth apps
    • 5.6.2.3 Digital therapeutics
    • 5.6.2.4 Telehealth platforms
  • 5.6.3 ADJACENT TECHNOLOGIES
    • 5.6.3.1 POC diagnostics
    • 5.6.3.2 Smart home health devices
• 5.7 TARIFF & REGULATORY ANALYSIS
  • 5.7.1 TARIFF DATA (HS CODE 9018)
  • 5.7.2 TARIFF DATA (HS CODE 9021)
  • 5.7.3 TARIFF DATA (HS CODE 9022)
  • 5.7.4 REGULATORY BODIES, GOVERNMENT AGENCIES, & OTHER ORGANIZATIONS
  • 5.7.5 REGULATORY ANALYSIS
• 5.8 TRADE ANALYSIS
  • 5.8.1 TRADE ANALYSIS FOR REMOTE PATIENT MONITORING DEVICES (HSN CODE: 90189099)
  • 5.8.2 TRADE ANALYSIS FOR REMOTE PATIENT MONITORING DEVICES (HSN CODE: 9021)
  • 5.8.3 TRADE ANALYSIS FOR REMOTE PATIENT MONITORING DEVICES (HSN CODE: 9022)
• 5.9 PRICING ANALYSIS
  • 5.9.1 INDICATIVE PRICING FOR REMOTE PATIENT MONITORING DEVICES, BY KEY PLAYER (2023)
  • 5.9.2 INDICATIVE PRICE FOR REMOTE PATIENT MONITORING DEVICES (2023)
• 5.10 PORTER'S FIVE FORCES ANALYSIS
  • 5.10.1 THREAT OF NEW ENTRANTS
  • 5.10.2 THREAT OF SUBSTITUTES
  • 5.10.3 BARGAINING POWER OF MANUFACTURERS
  • 5.10.4 BARGAINING POWER OF BUYERS
  • 5.10.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.11 PATENT ANALYSIS
  • 5.11.1 PATENT PUBLICATION TRENDS FOR REMOTE PATIENT MONITORING
  • 5.11.2 JURISDICTION AND TOP APPLICANT COUNTRIES FOR REMOTE PATIENT MONITORING
  • 5.11.3 LEADING PATENTS IN REMOTE PATIENT MONITORING MARKET
• 5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.12.2 BUYING CRITERIA
• 5.13 END-USER ANALYSIS
  • 5.13.1 UNMET NEEDS
  • 5.13.2 END-USER EXPECTATIONS
• 5.14 KEY CONFERENCES AND EVENTS, 2025-2026
  • 5.14.1 REMOTE PATIENT MONITORING MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2025-2026
• 5.15 CASE STUDY ANALYSIS
  • 5.15.1 REMOTE PATIENT MONITORING PORTAL AUTOMATION
    • 5.15.1.1 Case 1: Cost savings and performance boost through automation
  • 5.15.2 PATIENT MONITORING PORTAL AUTOMATION
    • 5.15.2.1 Case 2: RPM drives engagement and generates substantial returns
• 5.16 INVESTMENT AND FUNDING SCENARIO
• 5.17 REMOTE PATIENT MONITORING BUSINESS MODEL
  • 5.17.1 SUBSCRIPTION-BASED MODELS
  • 5.17.2 PLATFORM AS A SERVICE (PAAS)
  • 5.17.3 FREEMIUM MODELS WITH PREMIUM FEATURES
  • 5.17.4 COLLABORATIVE ECOSYSTEMS & PARTNERSHIPS
• 5.18 IMPACT OF GENERATIVE AI/AI ON REMOTE PATIENT MONITORING MARKET
  • 5.18.1 KEY USE CASES
  • 5.18.2 CASE STUDIES FOR GENERATIVE AI/AI IMPLEMENTATION
    • 5.18.2.1 Case study 1: Enhancing remote patient monitoring for cancer treatment with NLP and HIPAA-compliant annotation
    • 5.18.2.2 Case study 2: Leveraging AI for proactive infection prevention in hospitals
  • 5.18.3 IMPACT OF AI/GEN AI ON INTERCONNECTED & ADJACENT ECOSYSTEMS
    • 5.18.3.1 Telehealth & telemedicine
    • 5.18.3.2 Wearable devices
    • 5.18.3.3 Digital healthcare
    • 5.18.3.4 Home healthcare
  • 5.18.4 USER READINESS & IMPACT ASSESSMENT
    • 5.18.4.1 User readiness
      • 5.18.4.1.1 User A: Hospitals
      • 5.18.4.1.2 User B: Ambulatory surgery centers
    • 5.18.4.2 Impact assessment
      • 5.18.4.2.1 User A: Hospitals
        • 5.18.4.2.1.1 Implementation
        • 5.18.4.2.1.2 Impact
      • 5.18.4.2.2 User B: Ambulatory surgery centers
        • 5.18.4.2.2.1 Implementation
        • 5.18.4.2.2.2 Impact
• 5.19 REIMBURSEMENT SCENARIO

6 REMOTE PATIENT MONITORING MARKET, BY COMPONENT

• 6.1 INTRODUCTION
• 6.2 DEVICES
  • 6.2.1 BY FUNCTION
    • 6.2.1.1 Cardiac monitoring devices
      • 6.2.1.1.1 Increasing uptake of ECG monitors and rising cases of hypertension to fuel market
    • 6.2.1.2 Neurological monitoring devices
      • 6.2.1.2.1 Growing demand for clinical-grade wearable devices for routine monitoring to drive market
    • 6.2.1.3 Respiratory monitoring devices
      • 6.2.1.3.1 Rising demand for peak flow meters and sleep apnea monitors to fuel market
    • 6.2.1.4 Blood glucose monitoring devices
      • 6.2.1.4.1 Increasing prevalence of diabetes to support market growth
    • 6.2.1.5 Fetal & neonatal monitoring devices
      • 6.2.1.5.1 Growing focus on vital health monitoring in preterm births to drive market
    • 6.2.1.6 Weight monitoring devices
      • 6.2.1.6.1 High incidence of obesity and growing advancements in smart weighing scales to fuel market
    • 6.2.1.7 Multiparameter monitoring devices
      • 6.2.1.7.1 Measurement of spO2, blood sugar, and respiratory activity to fuel uptake
    • 6.2.1.8 Pulse oximeter devices
      • 6.2.1.8.1 Rising demand in preoperative & home care settings to support market growth
    • 6.2.1.9 Thermometers
      • 6.2.1.9.1 Growing focus on home healthcare to fuel market
    • 6.2.1.10 Other monitoring devices
  • 6.2.2 BY TYPE
    • 6.2.2.1 Wearable devices
      • 6.2.2.1.1 Ability to provide real-time insights to drive market
    • 6.2.2.2 Implantable devices
      • 6.2.2.2.1 Advancements in wireless communication technologies to boost demand
    • 6.2.2.3 Handheld & portable devices
      • 6.2.2.3.1 Growing focus on device miniaturization to fuel market
    • 6.2.2.4 Other devices
• 6.3 SOFTWARE
  • 6.3.1 SOFTWARE, BY DEPLOYMENT MODEL
    • 6.3.1.1 On-premise models
      • 6.3.1.1.1 Enhanced control, data security, and customization benefits to fuel market
    • 6.3.1.2 Cloud-based models
      • 6.3.1.2.1 Real-time data sharing and high-security features to boost demand
  • 6.3.2 SOFTWARE, BY TRANSMISSION TYPE
    • 6.3.2.1 Synchronous transmission
      • 6.3.2.1.1 Growing availability of real-time data analytics to boost demand
    • 6.3.2.2 Asynchronous transmission
      • 6.3.2.2.1 Increasing need for low-resource flexible solutions to support market growth
• 6.4 SERVICES
  • 6.4.1 EXPANSION OF TELEMEDICINE PLATFORMS AND INTEGRATION OF SERVICE MODELS TO SUPPORT MARKET GROWTH

7 REMOTE PATIENT MONITORING MARKET, BY INDICATION

• 7.1 INTRODUCTION
• 7.2 ONCOLOGY
  • 7.2.1 GROWING FOCUS ON EARLY DISEASE DETECTION TO DRIVE MARKET
• 7.3 CARDIOLOGY
  • 7.3.1 HIGH INCIDENCE OF CVD TO PROPEL MARKET
• 7.4 NEUROLOGY
  • 7.4.1 INCREASING PREVALENCE OF NEUROLOGICAL CONDITIONS TO FUEL MARKET
• 7.5 DIABETES
  • 7.5.1 GROWING FOCUS ON TELEHEALTH CONSULTATIONS FOR DIABETES MANAGEMENT TO BOOST DEMAND
• 7.6 SLEEP DISORDERS
  • 7.6.1 INCREASING INCIDENCE OF SLEEP APNEA TO SUPPORT MARKET GROWTH
• 7.7 RESPIRATORY DISEASES
  • 7.7.1 RISING CASES OF COPD AND ASTHMA TO FUEL MARKET
• 7.8 WELLNESS IMPROVEMENT
  • 7.8.1 UTILIZATION OF WEIGHT MANAGEMENT & PERSONAL HEALTH APPS TO SUPPORT MARKET GROWTH
• 7.9 MENTAL HEALTH
  • 7.9.1 GROWING FOCUS ON DEVELOPMENT OF PREDICTIVE HEALTH MODELS FOR COGNITIVE THERAPY TO PROPEL MARKET
• 7.10 OTHER INDICATIONS

8 REMOTE PATIENT MONITORING MARKET, BY END USER

• 8.1 INTRODUCTION
• 8.2 HEALTHCARE PROVIDERS
  • 8.2.1 HOSPITALS
    • 8.2.1.1 Ability to purchase technologically advanced telehealth devices to fuel market
  • 8.2.2 ASCS, ACCS, AND OTHER OUTPATIENT SETTINGS
    • 8.2.2.1 Increasing demand for cost-effective perioperative devices to fuel market
  • 8.2.3 LONG-TERM CARE & ASSISTED LIVING FACILITIES
    • 8.2.3.1 Expanding geriatric population and growing focus on chronic disease management to fuel market
  • 8.2.4 HOME HEALTHCARE
    • 8.2.4.1 Growing preference for remote care to drive market
  • 8.2.5 OTHER HEALTHCARE PROVIDERS
• 8.3 HEALTHCARE PAYERS
  • 8.3.1 LOW COSTS AND IMPROVED HEALTHCARE FACILITIES TO DRIVE MARKET
• 8.4 PATIENTS
  • 8.4.1 INCREASING FOCUS ON AI INTEGRATION INTO WEARABLE DEVICES TO BOOST DEMAND
• 8.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 8.5.1 RISING NEED FOR ENHANCED CLINICAL TRIAL OUTCOMES TO SUPPORT MARKET GROWTH
• 8.6 MEDTECH COMPANIES
  • 8.6.1 INTEGRATION OF RPM WITH MEDTECH SOLUTIONS FOR DIAGNOSTIC ACCURACY TO FUEL MARKET
• 8.7 OTHER END USERS

9 REMOTE PATIENT MONITORING MARKET, BY REGION

• 9.1 INTRODUCTION
• 9.2 NORTH AMERICA
  • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 9.2.2 US
    • 9.2.2.1 Supportive regulatory frameworks for AI implementation in wearable devices to boost demand
  • 9.2.3 CANADA
    • 9.2.3.1 Growing need to curtail healthcare costs to drive market
• 9.3 EUROPE
  • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 9.3.2 GERMANY
    • 9.3.2.1 Favorable reimbursements for technological innovation to propel market
  • 9.3.3 UK
    • 9.3.3.1 Government support for AI implementation to boost demand
  • 9.3.4 FRANCE
    • 9.3.4.1 Implementation of ETAPES program to fuel market
  • 9.3.5 ITALY
    • 9.3.5.1 Growing focus on digital transformation for value-centric patient care to drive market
  • 9.3.6 SPAIN
    • 9.3.6.1 Rising funding investments for digital health plans to boost market
  • 9.3.7 REST OF EUROPE
• 9.4 ASIA PACIFIC
  • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 9.4.2 CHINA
    • 9.4.2.1 Shortage of physicians and growing focus on RPM solutions to support market growth
  • 9.4.3 JAPAN
    • 9.4.3.1 Rising geriatric population and subsequent rise in preventive care to drive market
  • 9.4.4 INDIA
    • 9.4.4.1 Expanding target patient population to drive market
  • 9.4.5 REST OF ASIA PACIFIC
• 9.5 LATIN AMERICA
  • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 9.5.2 BRAZIL
    • 9.5.2.1 Growing focus on telehealth consultations to drive market
  • 9.5.3 MEXICO
    • 9.5.3.1 Improvements in healthcare infrastructure to boost demand
  • 9.5.4 REST OF LATIN AMERICA
• 9.6 MIDDLE EAST & AFRICA
• 9.7 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 9.7.1 GCC COUNTRIES
    • 9.7.1.1 Government initiatives for investments in RPM solutions to support market growth
  • 9.7.2 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
• 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN REMOTE PATIENT MONITORING MARKET
• 10.3 REVENUE ANALYSIS, 2019-2023
• 10.4 MARKET SHARE ANALYSIS, 2023
• 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 10.5.1 STARS
  • 10.5.2 EMERGING LEADERS
  • 10.5.3 PERVASIVE PLAYERS
  • 10.5.4 PARTICIPANTS
  • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 10.5.5.1 Company footprint
    • 10.5.5.2 Region footprint
    • 10.5.5.3 Component footprint
    • 10.5.5.4 Indication footprint
    • 10.5.5.5 End-user footprint
• 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 10.6.1 PROGRESSIVE COMPANIES
  • 10.6.2 RESPONSIVE COMPANIES
  • 10.6.3 DYNAMIC COMPANIES
  • 10.6.4 STARTING BLOCKS
  • 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    • 10.6.5.1 Detailed list of key startups/SMEs
    • 10.6.5.2 Competitive benchmarking of startups/SMEs
• 10.7 COMPANY VALUATION & FINANCIAL METRICS
  • 10.7.1 FINANCIAL METRICS
  • 10.7.2 COMPANY VALUATION
• 10.8 BRAND/SOFTWARE COMPARISON
• 10.9 COMPETITIVE SCENARIO
  • 10.9.1 PRODUCT/SERVICE LAUNCHES & APPROVALS
  • 10.9.2 DEALS
  • 10.9.3 EXPANSIONS
  • 10.9.4 OTHER DEVELOPMENTS

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
  • 11.1.1 KONINKLIJKE PHILIPS N.V.
    • 11.1.1.1 Business overview
    • 11.1.1.2 Products/Services offered
    • 11.1.1.3 Recent developments
      • 11.1.1.3.1 Product/Service launches & approvals
      • 11.1.1.3.2 Deals
    • 11.1.1.4 MnM view
      • 11.1.1.4.1 Key strengths
      • 11.1.1.4.2 Strategic choices
      • 11.1.1.4.3 Weaknesses & competitive threats
  • 11.1.2 OMRON HEALTHCARE, INC. (SUBSIDIARY OF OMRON CORPORATION)
    • 11.1.2.1 Business overview
    • 11.1.2.2 Products/Services offered
    • 11.1.2.3 Recent developments
      • 11.1.2.3.1 Product/Service launches
      • 11.1.2.3.2 Deals
      • 11.1.2.3.3 Other developments
    • 11.1.2.4 MnM view
      • 11.1.2.4.1 Key strengths
      • 11.1.2.4.2 Strategic choices
      • 11.1.2.4.3 Weaknesses & competitive threats
  • 11.1.3 MEDTRONIC
    • 11.1.3.1 Business overview
    • 11.1.3.2 Products/Services offered
    • 11.1.3.3 Recent developments
      • 11.1.3.3.1 Product/Service approvals
      • 11.1.3.3.2 Deals
    • 11.1.3.4 MnM view
      • 11.1.3.4.1 Key strengths
      • 11.1.3.4.2 Strategic choices
      • 11.1.3.4.3 Weaknesses & competitive threats
  • 11.1.4 GE HEALTHCARE
    • 11.1.4.1 Business overview
    • 11.1.4.2 Products/Services offered
    • 11.1.4.3 Recent developments
      • 11.1.4.3.1 Product/Service launches & approvals
      • 11.1.4.3.2 Deals
    • 11.1.4.4 MnM view
      • 11.1.4.4.1 Key strengths
      • 11.1.4.4.2 Strategic choices
      • 11.1.4.4.3 Weaknesses & competitive threats
  • 11.1.5 ABBOTT
    • 11.1.5.1 Business overview
    • 11.1.5.2 Products/Services offered
    • 11.1.5.3 Recent developments
      • 11.1.5.3.1 Product/Service launches
      • 11.1.5.3.2 Deals
      • 11.1.5.3.3 Expansions
    • 11.1.5.4 MnM view
      • 11.1.5.4.1 Key strengths
      • 11.1.5.4.2 Strategic choices
      • 11.1.5.4.3 Weaknesses & competitive threats
  • 11.1.6 ORACLE
    • 11.1.6.1 Business overview
    • 11.1.6.2 Products/Services offered
    • 11.1.6.3 Recent developments
      • 11.1.6.3.1 Deals
  • 11.1.7 BOSTON SCIENTIFIC CORPORATION
    • 11.1.7.1 Business overview
    • 11.1.7.2 Products/Services offered
    • 11.1.7.3 Recent developments
      • 11.1.7.3.1 Product/Service launches & enhancements
      • 11.1.7.3.2 Deals
      • 11.1.7.3.3 Expansions
  • 11.1.8 NIHON KOHDEN CORPORATION
    • 11.1.8.1 Business overview
    • 11.1.8.2 Products/Services offered
    • 11.1.8.3 Recent developments
      • 11.1.8.3.1 Product/Service launches
      • 11.1.8.3.2 Deals
      • 11.1.8.3.3 Expansions
  • 11.1.9 SIEMENS HEALTHINEERS AG
    • 11.1.9.1 Business overview
    • 11.1.9.2 Products/Services offered
    • 11.1.9.3 Recent developments
      • 11.1.9.3.1 Product/Service launches & approvals
      • 11.1.9.3.2 Deals
  • 11.1.10 BAXTER
    • 11.1.10.1 Business overview
    • 11.1.10.2 Products/Services offered
    • 11.1.10.3 Recent developments
      • 11.1.10.3.1 Product/Service launches & approvals
      • 11.1.10.3.2 Deals
  • 11.1.11 BIOBEAT
    • 11.1.11.1 Business overview
    • 11.1.11.2 Products/Services offered
    • 11.1.11.3 Recent developments
      • 11.1.11.3.1 Product/Service launches & approvals
      • 11.1.11.3.2 Deals
  • 11.1.12 BIOTRONIK
    • 11.1.12.1 Business overview
    • 11.1.12.2 Products/Services offered
    • 11.1.12.3 Recent developments
      • 11.1.12.3.1 Product/Service launches & approvals
      • 11.1.12.3.2 Deals
  • 11.1.13 VITALCONNECT
    • 11.1.13.1 Business overview
    • 11.1.13.2 Products/Services offered
    • 11.1.13.3 Recent developments
      • 11.1.13.3.1 Product/Service launches
      • 11.1.13.3.2 Deals
      • 11.1.13.3.3 Other developments
  • 11.1.14 VIVALNK, INC.
    • 11.1.14.1 Business overview
    • 11.1.14.2 Products/Services offered
    • 11.1.14.3 Recent developments
      • 11.1.14.3.1 Product/Service launches & enhancements
      • 11.1.14.3.2 Deals
  • 11.1.15 CLEARARCH, INC.
    • 11.1.15.1 Business overview
    • 11.1.15.2 Products/Services offered
    • 11.1.15.3 Recent developments
      • 11.1.15.3.1 Product/Service launches
      • 11.1.15.3.2 Deals
  • 11.1.16 OPTUM, INC. (VIVIFY HEALTH, PART OF OPTUM)
    • 11.1.16.1 Business overview
    • 11.1.16.2 Products/Services offered
  • 11.1.17 BLUE SPARK TECHNOLOGIES, INC.
    • 11.1.17.1 Business overview
    • 11.1.17.2 Products/Services offered
    • 11.1.17.3 Recent developments
      • 11.1.17.3.1 Product/Service launches
      • 11.1.17.3.2 Deals
      • 11.1.17.3.3 Other developments
  • 11.1.18 LIGHTBEAM
    • 11.1.18.1 Business overview
    • 11.1.18.2 Products/Services offered
    • 11.1.18.3 Recent developments
      • 11.1.18.3.1 Deals
  • 11.1.19 CLOUD DIAGNOSTICS CANADA ULC
    • 11.1.19.1 Business overview
    • 11.1.19.2 Products/Services offered
    • 11.1.19.3 Recent developments
      • 11.1.19.3.1 Product/Service launches
      • 11.1.19.3.2 Deals
  • 11.1.20 TELADOC HEALTH, INC.
    • 11.1.20.1 Business overview
    • 11.1.20.2 Products/Services offered
    • 11.1.20.3 Recent developments
      • 11.1.20.3.1 Product/Service launches
      • 11.1.20.3.2 Deals
  • 11.1.21 GUANGDONG TRANSTEK MEDICAL ELECTRONICS CO., LTD.
    • 11.1.21.1 Business overview
    • 11.1.21.2 Products/Services offered
    • 11.1.21.3 Recent developments
      • 11.1.21.3.1 Product/Service launches
• 11.2 OTHER PLAYERS
  • 11.2.1 CARESIMPLE INC.
  • 11.2.2 TIMEDOC, INC.
  • 11.2.3 MD REVOLUTION INC.
  • 11.2.4 OPTIMIZE HEALTH, INC.
  • 11.2.5 HEALTH RECOVERY SOLUTIONS

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS